Esperion Therapeutics Inc... (ESPR)
NASDAQ: ESPR
· Real-Time Price · USD
2.06
-0.01 (-0.48%)
At close: Aug 15, 2025, 3:59 PM
2.05
-0.24%
After-hours: Aug 15, 2025, 07:46 PM EDT
Esperion Therapeutics Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -153.22M | -51.74M | -86.77M | -98.5M | -86.51M | -209.25M | -208.39M | -222.26M | -238.65M | -233.66M | -243.29M | -257.56M | -234.9M | -269.11M | -308.46M | -324.52M | -156.24M |
Depreciation & Amortization | 351K | 63K | 42K | 479K | 520K | 164K | 250K | 329K | 428K | 500K | 561K | 609K | 612K | 612K | 619K | 629K | 594K |
Stock-Based Compensation | 11.22M | 11.99M | 12.11M | 12.06M | 12.29M | 11.96M | 12.75M | 13.31M | 13.68M | 15.21M | 15.97M | 17.93M | 22.99M | 24.31M | 26.5M | 28.27M | 27.08M |
Other Working Capital | -17.52M | -12.45M | 9.97M | 19.03M | 39.63M | 50.18M | 32.88M | 15.54M | 12.8M | 2.63M | 745K | 8.06M | -136K | 5.13M | 257.63M | 255.68M | 253.2M |
Other Non-Cash Items | 68.24M | 77M | 102.05M | 110.39M | 65.5M | 65.52M | 47.05M | 46.38M | 46.3M | 46.49M | 46.07M | 45.26M | 41.79M | 35.53M | 44.59M | 38.66M | 34.95M |
Deferred Income Tax | n/a | n/a | -17.49M | -17.49M | -17.56M | -17.56M | -73K | -73K | n/a | n/a | -2.63M | -2.63M | -2.63M | -2.63M | n/a | -4K | -24K |
Change in Working Capital | -26.7M | -60.53M | -35.27M | -16.27M | -1.11M | 13.68M | 7.51M | -2.1M | -11.96M | -3.37M | -6.74M | -20M | -41.59M | -52.51M | -37.9M | -35.2M | -11.27M |
Operating Cash Flow | -100.11M | -23.65M | -25.76M | -9.76M | -27.3M | -135.49M | -140.9M | -164.41M | -190.19M | -174.83M | -190.06M | -216.4M | -213.73M | -263.81M | -274.65M | -292.15M | -104.9M |
Capital Expenditures | -244K | -317K | -317K | -150K | -73K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -12.68M | -12.59M | -13.18M |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | -41.8M | -41.8M | -41.8M | -59.9M | -68.59M | -68.59M | -68.59M | -50.48M | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | 17.5M | 42.5M | 72.5M | 105.5M | 93M | 68M | 38M | 5M | n/a | n/a | n/a | 2.25M | 7.95M |
Other Investing Acitivies | n/a | n/a | -42.5M | -42.5M | -25M | n/a | 30.71M | 63.71M | 51.21M | 8.1M | -30.59M | -63.59M | -68.59M | -50.48M | -12.5M | -10.25M | -4.55M |
Investing Cash Flow | -244K | -317K | -317K | -150K | 17.43M | 42.5M | 30.71M | 63.71M | 51.21M | 8.1M | -30.59M | -63.59M | -68.59M | -50.48M | -12.68M | -10.34M | -5.23M |
Debt Repayment | 25.39M | 25.39M | -9.63M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | -343.75M | -343.75M | -343.75M | -343.77M | -20K | -20K | -20K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -55M | -55M | -55M |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -37.52M | -30.09M | -78.05M | -29.9M | 933K | -2.11M | -6.5M | -57M | -59.91M | -58.24M | -6.79M | -5.16M | 46.05M | 49.53M | 220.87M | 223.19M | 177.76M |
Financial Cash Flow | -11.62M | 86.48M | 55.96M | 60.74M | 91.57M | 50.46M | 15.63M | 66.23M | 83.53M | 32.61M | 276.37M | 233.74M | 264.74M | 268.22M | 225.25M | 223.19M | 177.76M |
Net Cash Flow | -111.98M | 62.51M | 29.88M | 50.83M | 81.7M | -42.53M | -94.57M | -34.47M | -55.45M | -134.12M | 55.73M | -46.25M | -17.57M | -46.07M | -62.08M | -79.3M | 67.63M |
Free Cash Flow | -100.35M | -23.97M | -26.07M | -9.91M | -27.38M | -135.49M | -140.9M | -164.41M | -190.19M | -174.83M | -190.06M | -216.4M | -213.73M | -263.81M | -287.33M | -304.75M | -118.08M |